Description
Despite recent FDA approvals of multiple disease-modifying therapies, none can halt progression or reverse ALS course. Understanding this therapeutic ceiling is critical for developing more effective interventions that could meaningfully alter disease trajectory.
Gap type: open_question Source paper: Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases. (2023, Continuum (Minneapolis, Minn.), PMID:37851042)
Resolution criteria
Resolution requires: (1) Systematic review and meta-analysis of >=5 ALS clinical trials (phasetherapies targeting SOD1, C9orf72, TDP-43, or general neuroprotection) identifying specific mechanistic failure points (target engagement, blood-brain barrier penetration, patient stratification); (2) Biomarker evidence from trial participant samples establishing whether failure is due to insufficient target modulation (>=50% of patients below therapeutic threshold) or wrong disease subtype; (3) Prospective demonstration in a well-powered trial (n>=100 per arm) that a therapy addressing identified failure points produces clinically meaningful slowing of disease progression (ALSFRS-R decline rate reduction >=25%). Retrospective analysis alone without prospective validation is insufficient.
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:28.497596+00:00”, “resolution_summary”: “Resolved by hypothesis h-alsmnd-e448328ae294: GLE1-Mediated mRNA Export Defect Creates Translation-Competent mRNA Starvation in ALS Motor Neuron Axons. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-alsmnd-e448328ae294”, “title”: “GLE1-Mediated mRNA Export Defect Creates Translation-Competent mRNA Starvation in ALS Motor Neuron Axons”, “score”: 0.236, “reason”: “9 token overlaps; entity overlap: als”, “analysis_id”: null, “target_gene”: “GLE1,DBP10,EXPORTIN-1,XPO1,mRNA export machinery,NPC”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.822847, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“25343993”, “26776475”, “26921650”, “34025336”]}, {“id”: “h-6fe30c39bc”, “title”: “STING Antagonists as ALS Therapeutics: Drug Repurposing”, “score”: 0.234, “reason”: “22 token overlaps; entity overlap: als”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-fc60e018”, “target_gene”: “STING (TMEM173)”, “target_pathway”: null, “disease”: “neuroinflammation”, “composite_score”: 0.771164, “confidence_score”: 0.68, “status”: “proposed”, “pubmed_evidence_ids”: [“29346698”, “33031745”, “33147677”, “34644542”, “41380972”]}, {“id”: “h-alsmnd-006d646506ab”, “title”: “hnRNP A2/B1 Staufen2-Mediated Axonal RNA Granule Transport Failure Drives Distal Axon Degeneration in ALS”, “score”: 0.228, “reason”: “8 token overlaps; entity overlap: als”, “analysis_id”: null, “target_gene”: “HNRNPA2B1,STAU2,PRMT1,GSK3B,MAP1B,β-actin,axonal transport machinery”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.851136, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“30344044”, “34290090”, “40737092”, “41044342”]}, {“id”: “h-f373e16bb108”, “title”: “EZH2-Mediated H3K27me3 Spreading in Senescent ALS Microglia Silences Neuroprotective Gene Programs — Reversible by EZH2 Inhibitors”, “score”: 0.226, “reason”: “10 token overlaps; entity overlap: als”, “analysis_id”: “SDA-2026-04-26-gap-20260425215446”, “target_gene”: “EZH2 (PRC2) → H3K27me3 silencing of BDNF, GRN, TREM2, MerTK”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.7136330000000001, “confidence_score”: 0.28, “status”: “proposed”, “pubmed_evidence_ids”: [“31048495”, “31202798”, “32553389”, “32933418”]}, {“id”: “h-3156f6bcd349”, “title”: “GPX4 reserve failure gates selective ALS motor-neuron ferroptosis”, “score”: 0.221, “reason”: “4 token overlaps; entity overlap: als”, “analysis_id”: “SDA-2026-04-26-gap-ferroptosis-mnd-768eaeba1be3”, “target_gene”: “GPX4”, “target_pathway”: “ferroptosis”, “disease”: “neurodegeneration”, “composite_score”: 0.745, “confidence_score”: 0.72, “status”: “proposed”, “pubmed_evidence_ids”: [“29916020”, “31185581”, “38891021”, “38967083”, “38989463”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.578, “reason”: “12 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046_task_9aae8fc5”, “title”: “While the study establishes TDP-43 triggers mtDNA release via mPTP to activate cGAS/STING, it’s unclear why this pathway preferentially affects motor neurons in ALS when TDP-43 pathology occurs in multiple cell types. Understanding this selectivity is crucial for targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.521, “reason”: “11 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046”, “quality_score”: 0.734, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852”, “title”: “The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Understanding this connection is critical for developing targeted therapies that could prevent early pathogenic events in VCP-ALS.\n\nGap type: unexplained_observation\nSource paper: Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes. (2026, Stem cell reports, PMID:41349534)”, “score”: 0.503, “reason”: “11 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “title”: “The authors evaluate several ALS-associated mutations in OPTN’s leucine-zipper domain but don’t fully explain how these mutations mechanistically lead to disease pathogenesis. Understanding this link is critical for developing targeted ALS therapies.\n\nGap type: unexplained_observation\nSource paper: Molecular Basis of the Recognition of the Active Rab8a by Optineurin. (2024, Journal of molecular biology, PMID:39374890)”, “score”: 0.496, “reason”: “10 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062212-6777e5dd_task_9aae8fc5”, “title”: “While ALS-causing mutations impair autophagy factors, the neuron-specific effects remain incompletely defined according to the authors. This knowledge gap prevents precise understanding of selective neuronal vulnerability in ALS.\n\nGap type: open_question\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.485, “reason”: “9 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062212-6777e5dd”, “quality_score”: 0.812, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}